BDTX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -2.41. Updated 2026-07-23.
Black Diamond Therapeutics (BDTX) Research Hub
Black Diamond Therapeutics (BDTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.98 USD (-5.71%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.41, market cap 0.10B. This hub links to the full technical, earnings and options research available for BDTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.98 USD (-5.71%) |
| 52-week range | 1.61 USD – 2.29 USD |
| Trend regime | Range |
| 14-day RSI | 51.6 (Neutral) |
| Trailing P/E | -2.41 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for BDTX
Covered Call on BDTX: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BDTX: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BDTX: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
BDTX technical analysis: range, last 1.98 USD, RSI 51.6, 52w range 1.61 USD–2.29 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BDTX in?
Black Diamond Therapeutics (BDTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BDTX in an uptrend or downtrend?
As of 2026-09-11, BDTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BDTX's trailing P/E ratio?
BDTX's trailing P/E is -2.41, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does BDTX next report earnings?
BDTX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.18 USD.